p38 Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p38 Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes
Authors
Keywords
-
Journal
Molecular Pain
Volume 6, Issue -, Pages 1744-8069-6-28
Publisher
SAGE Publications
Online
2010-05-20
DOI
10.1186/1744-8069-6-28
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Neuropathic Pain: An Overview of Recent Guidelines
- (2009) Alec B. O'Connor et al. AMERICAN JOURNAL OF MEDICINE
- Nerve Growth Factor Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes
- (2009) Hsinlin T. Cheng et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Activation of Cytosolic Phospholipase A2 in Dorsal Root Ganglion Neurons by Ca2+/Calmodulin-Dependent Protein Kinase II after Peripheral Nerve Injury
- (2009) Shigeo Hasegawa et al. Molecular Pain
- Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing
- (2009) Jessica A. Cottrell et al. PAIN
- Periganglionic inflammation elicits a distally radiating pain hypersensitivity by promoting COX-2 induction in the dorsal root ganglion
- (2009) Fumimasa Amaya et al. PAIN
- p38MAPK: stress responses from molecular mechanisms to therapeutics
- (2009) Lydia R. Coulthard et al. TRENDS IN MOLECULAR MEDICINE
- Ameliorative Potential of Spironolactone in Diabetes Induced Hyperalgesia in Mice
- (2009) Nadeem KHAN et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- MAP kinase and pain
- (2008) Ru-Rong Ji et al. BRAIN RESEARCH REVIEWS
- Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy
- (2008) Rodica Pop-Busui et al. CURRENT DRUG TARGETS
- Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes
- (2008) I. Vareniuk et al. DIABETOLOGIA
- Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model
- (2008) Kyung-Min Lee et al. EUROPEAN JOURNAL OF PAIN
- Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury
- (2008) Eric D. Crown et al. EXPERIMENTAL NEUROLOGY
- P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
- (2008) Kimberly K Brown et al. Journal of Inflammation-London
- Differential Activation of p38 and Extracellular Signal-Regulated Kinase in Spinal Cord in a Model of Bee Venom-Induced Inflammation and Hyperalgesia
- (2008) Xiu-Yu Cui et al. Molecular Pain
- Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-d-aspartate receptor in spinal cord dorsal horn
- (2008) H.T. Cheng et al. NEUROSCIENCE
- Diabetic neuropathy: Mechanisms to management
- (2008) James L. Edwards et al. PHARMACOLOGY & THERAPEUTICS
- IL-1β signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2
- (2007) Wendy Kleibeuker et al. BRAIN BEHAVIOR AND IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started